Literature DB >> 4028377

Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study.

M H Criqui, S S Coughlin, A Fronek.   

Abstract

Intermittent claudication has been reported in previous studies to approximately double the risk of subsequent mortality. However, a history of claudication is often present in the absence of significant peripheral arterial disease (PAD) and absent in the presence of PAD. For this reason we evaluated the association between large-vessel and small-vessel PAD, measured by highly reliable and valid noninvasive tests, and mortality in 567 older subjects from a defined population followed-up for an average of 4 years. Large-vessel PAD was strongly and significantly predictive of all-cause mortality in both men and women with a relative risk of 4 to 5, and this finding was independent of other cardiovascular disease risk factors in multivariable analysis. In addition, this finding persisted after exclusion of subjects with extant cardiovascular disease at baseline. The associations of both claudication and abnormal peripheral pulses with mortality were weaker than the large-vessel PAD association. Isolated small-vessel PAD was unrelated to subsequent mortality. These findings suggest older subjects of both sexes at a high risk of impending mortality can be identified through noninvasive testing for large-vessel PAD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028377     DOI: 10.1161/01.cir.72.4.768

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

2.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Coronary disease and stroke in patients with large-vessel peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 5.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

6.  Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhoj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

7.  A combination of experimental and numerical methods to investigate the role of strain rate on the mechanical properties and collagen fiber orientations of the healthy and atherosclerotic human coronary arteries.

Authors:  Alireza Karimi; Seyyed Mohammadali Rahmati; Toshihiro Sera; Susumu Kudo; Mahdi Navidbakhsh
Journal:  Bioengineered       Date:  2016-09-02       Impact factor: 3.269

8.  Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Wilbert S Aronow; Michael H Criqui; Inmaculada Aban; Thomas E Love; Eric J Eichhorn; Ali Ahmed
Journal:  Circ Heart Fail       Date:  2009-10-27       Impact factor: 8.790

Review 9.  [Evidence-based recommendations on primary diagnostics of peripheral arterial occlusive disease in geriatric patients].

Authors:  C Ploenes; H Görtz; T Heimig; M Meisel; C Naumann; R Sultzer
Journal:  Z Gerontol Geriatr       Date:  2009-09-10       Impact factor: 1.281

Review 10.  Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.

Authors:  T De Backer; R Vander Stichele; P Lehert; L Van Bortel
Journal:  BMJ       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.